Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Ex VP & Pres Elanco Europe | November 30, 2021 | December 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date November 30, 2021 · Filed December 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,241 |
Reported balance
After 2021-11-30 transaction · row 1
1 source rowRow 1 · 2021-11-30 · Tax withholding · Disposed 739 · Balance 11,241 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2021 Filed Dec 2, 2021 22:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 739 | $28.74 | $21,238.86 |
DisclosureSEC source: 0001179110-21-010536 · edgar.xml · nonDerivative · entry 1 Ehle Dirk · CIK 0001820671 · Ex VP & Pres Elanco Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,241 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:00 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000182 · edgar.xml · nonDerivative · entry 1 Ehle Dirk · CIK 0001820671 · Ex VP & Pres Elanco Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,980 F1 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2021, one-third vesting on March 1, 2022, one-third vesting on March 1, 2023, and the remaining vesting on March 1, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,322 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000394 · edgar.xml · nonDerivative · entry 3 Ehle Dirk · CIK 0001820671 · Ex VP & Pres Elanco Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,188 F3 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 1, 2020, vesting on November 30, 2023. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 3,432 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000394 · edgar.xml · nonDerivative · entry 2 Ehle Dirk · CIK 0001820671 · Ex VP & Pres Elanco Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,866 F2 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 1, 2020, vesting on November 30, 2022. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 1,434 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000394 · edgar.xml · nonDerivative · entry 1 Ehle Dirk · CIK 0001820671 · Ex VP & Pres Elanco Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 1, 2020, vesting on November 30, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.